MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
Apollo Endosurgery Operating Income 2011-2026 | APEN
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -31.4 M | -19.2 M | -15.8 M | -23.5 M | -40.1 M | -22.4 M | -20.8 M | -16.7 M | -17.8 M | -7.59 M | -5.56 M | -3.71 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -3.71 M | -40.1 M | -18.7 M |
Quarterly Operating Income Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -6.29 M | - | -7.25 M | - | -4.5 M | -5.24 M | -3.75 M | - | -1.57 M | -4.3 M | -6.68 M | - | -6.86 M | -7.2 M | -2.54 M | - | -8.1 M | -7.51 M | -7.63 M | - | -4.28 M | -5.47 M | -6.81 M | - | -3.72 M | -6.26 M | -3.02 M | - | -2.23 M | -3.27 M | -3.02 M | - | -3.57 M | -4.33 M | -3.1 M | - | -1.78 M | -1.93 M | -1.48 M | - | -1.35 M | -1.08 M | -1.23 M | - | -701 K | -632 K | 96 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 96 K | -8.1 M | -3.96 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
230 M | - | - | $ 17.2 B |  USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
-136 M | $ 21.04 | 0.86 % | $ 3.01 B | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Apyx Medical Corporation
APYX
|
-17.3 M | $ 3.5 | 1.74 % | $ 121 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 9.4 | 1.08 % | $ 675 M |  Israel |
 |
Boston Scientific Corporation
BSX
|
2.6 B | $ 95.35 | -0.69 % | $ 140 B | USA |
 |
Bio-Rad Laboratories
BIO
|
269 M | $ 302.99 | -0.5 % | $ 8.55 B | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 47.11 | -0.84 % | $ 7.02 K | USA |
 |
Electromed
ELMD
|
9.66 M | $ 29.12 | 1.01 % | $ 246 M | USA |
 |
Abbott Laboratories
ABT
|
6.82 B | $ 125.29 | -0.39 % | $ 218 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.29 | 2.49 % | $ 123 M |  France |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
IRadimed Corporation
IRMD
|
22 M | $ 97.28 | -0.5 % | $ 1.23 B | USA |
 |
Zynex
ZYXI
|
5.99 M | - | - | $ 21.1 M | USA |
 |
InMode Ltd.
INMD
|
113 M | $ 14.69 | -1.01 % | $ 1.17 B | Israel |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
608 M | $ 156.15 | -1.26 % | $ 11.7 B | USA |
 |
Accuray Incorporated
ARAY
|
7.84 M | $ 0.82 | 2.64 % | $ 84.3 M | USA |
 |
LivaNova PLC
LIVN
|
129 M | $ 61.53 | -1.2 % | $ 3.34 B |  Britain |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
|
LENSAR
LNSR
|
-10.7 M | $ 11.63 | - | $ 134 M | USA |
 |
ClearPoint Neuro
CLPT
|
-19.7 M | $ 13.68 | 0.81 % | $ 370 M | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.56 | -0.22 % | $ 122 M | USA |
 |
AxoGen
AXGN
|
-3.29 M | $ 32.73 | - | $ 1.45 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.14 | -0.87 % | $ 18.4 M | USA |
 |
CONMED Corporation
CNMD
|
200 M | $ 40.6 | -1.31 % | $ 1.25 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-35 M | $ 17.76 | -1.11 % | $ 410 M | USA |
 |
Globus Medical
GMED
|
166 M | $ 87.31 | -0.68 % | $ 11.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 12.42 | -2.05 % | $ 956 M | USA |
 |
Myomo
MYO
|
-10.7 M | $ 0.91 | -1.58 % | $ 6.42 M | USA |